Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys561
Sells10479
Buy $$26.17B
Sell $$15.81B
Ratio1.66:1
% Change vs. Prior
Ratio +758.9%Value +344.5%
Healthcare
Buys633
Sells4608
Buy $$531.16M
Sell $$9.96B
Ratio1:18.74
% Change vs. Prior
Ratio -22.5%Value -31.3%
Industrials
Buys411
Sells2023
Buy $$346.65M
Sell $$7.31B
Ratio1:21.10
% Change vs. Prior
Ratio +143.4%Value +34.5%
Consumer Cyclical
Buys360
Sells2071
Buy $$1.15B
Sell $$3.88B
Ratio1:3.36
% Change vs. Prior
Ratio +4.3%Value +67.7%
Financial Services
Buys1369
Sells2780
Buy $$691.78M
Sell $$4.00B
Ratio1:5.78
% Change vs. Prior
Ratio -28.3%Value -22.8%
Energy
Buys301
Sells588
Buy $$137.50M
Sell $$4.39B
Ratio1:31.93
% Change vs. Prior
Ratio +269.0%Value -11.0%
Consumer Defensive
Buys150
Sells751
Buy $$133.62M
Sell $$2.23B
Ratio1:16.71
% Change vs. Prior
Ratio +27.7%Value +71.3%
Utilities
Buys67
Sells279
Buy $$70.18M
Sell $$1.42B
Ratio1:20.29
% Change vs. Prior
Ratio +19399.0%Value -78.1%
Communication Services
Buys115
Sells858
Buy $$128.26M
Sell $$1.33B
Ratio1:10.35
% Change vs. Prior
Ratio +48.9%Value +38.6%
Basic Materials
Buys137
Sells266
Buy $$67.67M
Sell $$560.71M
Ratio1:8.29
% Change vs. Prior
Ratio -51.0%Value -32.9%
Real Estate
Buys183
Sells319
Buy $$97.20M
Sell $$248.87M
Ratio1:2.56
% Change vs. Prior
Ratio +244.3%Value +1.9%
By Industry
Hardware, Equipment & Parts
Buys29
Sells872
Buy $$25.82B
Sell $$738.42M
Ratio34.97:1
% Change vs. Prior
Ratio +2253.7%Value +1620.7%
Software - Infrastructure
Buys71
Sells3473
Buy $$52.48M
Sell $$5.10B
Ratio1:97.13
% Change vs. Prior
Ratio -45.5%Value +197.2%
Medical - Instruments & Supplies
Buys41
Sells104
Buy $$16.73M
Sell $$3.66B
Ratio1:218.71
% Change vs. Prior
Ratio +26.4%Value -52.3%
Semiconductors
Buys113
Sells1797
Buy $$3.15M
Sell $$3.02B
Ratio1:959.05
% Change vs. Prior
Ratio -75.6%Value +25.2%
Oil & Gas Exploration & Production
Buys178
Sells122
Buy $$47.75M
Sell $$2.72B
Ratio1:56.92
% Change vs. Prior
Ratio +440.5%Value -19.1%
Computer Hardware
Buys3
Sells1701
Buy $$104.50K
Sell $$2.45B
Ratio1:23412.80
Biotechnology
Buys380
Sells3208
Buy $$445.09M
Sell $$1.91B
Ratio1:4.29
% Change vs. Prior
Ratio -39.8%Value -7.5%
Software - Application
Buys265
Sells1650
Buy $$273.67M
Sell $$2.06B
Ratio1:7.51
% Change vs. Prior
Ratio -59.3%Value +17.0%
Engineering & Construction
Buys12
Sells247
Buy $$1.80M
Sell $$2.32B
Ratio1:1288.21
Specialty Retail
Buys79
Sells1020
Buy $$22.00M
Sell $$2.05B
Ratio1:93.01
% Change vs. Prior
Ratio -93.2%Value +42.3%
Medical - Healthcare Information Services
Buys33
Sells231
Buy $$18.91M
Sell $$1.87B
Ratio1:98.97
% Change vs. Prior
Ratio -8.4%Value +6.5%
Rental & Leasing Services
Buys7
Sells130
Buy $$2.92M
Sell $$1.88B
Ratio1:643.68
Shell Companies
Buys116
Sells312
Buy $$121.27M
Sell $$1.49B
Ratio1:12.32
% Change vs. Prior
Ratio +73.4%Value +82.5%
Information Technology Services
Buys65
Sells226
Buy $$9.78M
Sell $$1.42B
Ratio1:144.97
Leisure
Buys29
Sells95
Buy $$7.63M
Sell $$1.29B
Ratio1:168.98
Transactions (29784)
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,803
Price
$308.89
Total Value
$1.17M
Shares Held After
1,383,235
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
12,729
Price
$307.81
Total Value
$3.92M
Shares Held After
1,387,038
% of Holdings
0.9%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,348
Price
$307.09
Total Value
$413.96K
Shares Held After
1,399,767
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
480
Price
$305.87
Total Value
$146.82K
Shares Held After
1,401,115
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
400
Price
$304.89
Total Value
$121.96K
Shares Held After
1,401,595
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
247
Price
$303.17
Total Value
$74.88K
Shares Held After
1,401,995
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
593
Price
$302.25
Total Value
$179.23K
Shares Held After
1,402,242
% of Holdings
0.0%
ICHOR HOLDINGS, LTD. (ICHR)
BARROS PHILIP RYAN SR. — Director
Shares
13,705
Price
$70.19
Total Value
$961.95K
Shares Held After
165,078
% of Holdings
7.7%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,402,835
% of Holdings
0.0%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
100
Price
$9.00
Total Value
$900.00
Shares Held After
875,459
% of Holdings
0.0%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
8,939
Price
$37.09
Total Value
$331.54K
Shares Held After
64,620
% of Holdings
12.2%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
7,000
Price
$36.51
Total Value
$255.56K
Shares Held After
73,559
% of Holdings
8.7%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
4,900
Price
$35.47
Total Value
$173.78K
Shares Held After
80,559
% of Holdings
5.7%
Pacira BioSciences, Inc. (PCRX)
WILLIAMS KRISTEN — Chief Administrative Officer
Shares
10,259
Price
$22.27
Total Value
$228.47K
Shares Held After
167,062
% of Holdings
5.8%
TJX COMPANIES INC /DE/ (TJX)
Herrman Ernie — Director
Shares
28,000
Price
$158.32
Total Value
$4.43M
Shares Held After
524,850
% of Holdings
5.1%
NovoCure Ltd (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
34,273
Price
$17.93
Total Value
$614.63K
Shares Held After
459,520
% of Holdings
6.9%
California Resources Corp (CRC)
Bys Jay A. — EVP & Chief Commercial Officer
Shares
11,907
Price
$61.68
Total Value
$734.42K
Shares Held After
171,331
% of Holdings
6.5%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
1,000
Price
$12.80
Total Value
$12.80K
Shares Held After
21,969
% of Holdings
4.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$12.68
Total Value
$6.34K
Shares Held After
22,969
% of Holdings
2.1%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$54.50
Total Value
$54.50K
Shares Held After
0
% of Holdings
100.0%
SmartRent, Inc. (SMRT)
Martell Frank — Director
Shares
20,000
Price
$1.19
Total Value
$23.73K
Shares Held After
3,185,266
% of Holdings
0.6%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
826
Price
$87.91
Total Value
$72.61K
Shares Held After
802,708
% of Holdings
0.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
8,581
Price
$87.13
Total Value
$747.66K
Shares Held After
803,534
% of Holdings
1.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
10,992
Price
$86.07
Total Value
$946.08K
Shares Held After
812,115
% of Holdings
1.3%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
17,543
Price
$85.11
Total Value
$1.49M
Shares Held After
823,107
% of Holdings
2.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
2,060
Price
$83.86
Total Value
$172.75K
Shares Held After
840,650
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$550.48
Total Value
$66.06K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,298
Price
$549.06
Total Value
$712.68K
Shares Held After
18,996
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,749
Price
$548.04
Total Value
$1.51M
Shares Held After
20,294
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,033
Price
$547.00
Total Value
$565.05K
Shares Held After
23,043
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,129
Price
$545.89
Total Value
$616.31K
Shares Held After
24,076
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,545
Price
$544.94
Total Value
$841.94K
Shares Held After
25,205
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,086
Price
$544.11
Total Value
$590.91K
Shares Held After
26,750
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$542.78
Total Value
$238.82K
Shares Held After
27,836
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$541.14
Total Value
$259.75K
Shares Held After
28,276
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$539.64
Total Value
$64.76K
Shares Held After
28,756
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
HALKUFF DAWN — Director
Shares
20,000
Price
$6.09
Total Value
$121.89K
Shares Held After
95,000
% of Holdings
17.4%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,104
Price
$34.67
Total Value
$142.29K
Shares Held After
211,930
% of Holdings
1.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
25,896
Price
$34.01
Total Value
$880.72K
Shares Held After
216,034
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
JOHNSON JOHN — Director
Shares
15,000
Price
$6.09
Total Value
$91.42K
Shares Held After
683,083
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$550.46
Total Value
$308.26K
Shares Held After
40,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$549.24
Total Value
$428.41K
Shares Held After
41,073
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,676
Price
$548.26
Total Value
$918.89K
Shares Held After
41,853
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.53
Total Value
$834.98K
Shares Held After
43,529
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$546.14
Total Value
$656.46K
Shares Held After
45,054
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,186
Price
$545.18
Total Value
$646.59K
Shares Held After
46,256
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,470
Price
$544.24
Total Value
$800.04K
Shares Held After
47,442
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
396
Price
$543.11
Total Value
$215.07K
Shares Held After
48,912
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
112
Price
$542.50
Total Value
$60.76K
Shares Held After
49,308
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
473
Price
$541.08
Total Value
$255.93K
Shares Held After
49,420
% of Holdings
0.9%
Showing 5851–5900 of 29784 transactions (page 118 of 596)